Technical Analysis for NTEC - Intec Pharma Ltd.

Grade Last Price % Change Price Change
grade D 6.75 -2.60% -0.18
NTEC closed down 2.6 percent on Monday, March 18, 2019, on 53 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical NTEC trend table...

Date Alert Name Type % Chg
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 Inside Day Range Contraction -2.60%
Mar 15 Wide Bands Range Expansion -2.60%
Mar 15 Oversold Stochastic Weakness -2.60%
Mar 14 180 Bearish Setup Bearish Swing Setup 0.15%
Mar 14 Wide Bands Range Expansion 0.15%
Mar 14 Oversold Stochastic Weakness 0.15%
Mar 13 Slingshot Bearish Bearish Swing Setup -6.51%
Mar 13 Wide Bands Range Expansion -6.51%

Older signals for NTEC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Intec Pharma Ltd., a drug development company, develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill, in Israel. The Accordion Pill, a novel gastro-retentive delivery system improves the pharmacokinetics and pharmacodynamics of various drugs. The company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson's disease patients. Its pipeline also comprises The Accordion Pill – Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Intec Pharma Ltd. is based in Jerusalem, Israel.
Chemistry Physical Sciences Drugs Drug Development Parkinson's Disease Pharmacokinetics Pharmacodynamics L Dopa
Is NTEC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.25
52 Week Low 3.55
Average Volume 268,870
200-Day Moving Average 5.8145
50-Day Moving Average 7.9764
20-Day Moving Average 7.9815
10-Day Moving Average 7.154
Average True Range 0.4567
ADX 33.11
+DI 12.4466
-DI 31.722
Chandelier Exit (Long, 3 ATRs ) 7.8799
Chandelier Exit (Short, 3 ATRs ) 7.9201
Upper Bollinger Band 9.7713
Lower Bollinger Band 6.1917
Percent B (%b) 0.16
BandWidth 44.848713
MACD Line -0.3604
MACD Signal Line -0.1854
MACD Histogram -0.1749
Fundamentals Value
Market Cap 92.73 Million
Num Shares 13.7 Million
EPS -1.50
Price-to-Earnings (P/E) Ratio -4.50
Price-to-Sales 0.00
Price-to-Book 5.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.20
Resistance 3 (R3) 7.23 7.12 7.13
Resistance 2 (R2) 7.12 7.00 7.10 7.10
Resistance 1 (R1) 6.93 6.93 6.88 6.90 7.07
Pivot Point 6.82 6.82 6.79 6.80 6.82
Support 1 (S1) 6.63 6.70 6.58 6.60 6.43
Support 2 (S2) 6.52 6.63 6.50 6.40
Support 3 (S3) 6.33 6.52 6.38
Support 4 (S4) 6.30